These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34768648)

  • 1. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Raisakis K; Kossyvakis C; Kaoukis A; Kolokathis F; Deftereos G; Iliodromitis KE; Avramides D; Bogossian H; Siasos G; Giannopoulos G; Reimers B; Lansky A; Tardif JC; Deftereos S
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos AA; Pelechas E; Drossou V; Voulgari PV
    Rheumatol Ther; 2022 Apr; 9(2):379-389. PubMed ID: 35107804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in COVID-19: an Old Drug, New Use.
    Schlesinger N; Firestein BL; Brunetti L
    Curr Pharmacol Rep; 2020; 6(4):137-145. PubMed ID: 32837853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing colchicine's journey in view of drug-to-drug interactions. A review.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Iliodromitis KE; Papaioannou TG; Stefanini GG; Cleman M; Siasos G; Reimers B; Lansky A; Tardif JC; Deftereos SG; Giannopoulos G
    Toxicol Rep; 2021; 8():1389-1393. PubMed ID: 34285885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of the Rational and Current Evidence on Colchicine for COVID-19.
    Ghaith HS; Gabra MD; Nafady MH; Elshawah HE; Negida A; Mushtaq G; Kamal MA
    Curr Pharm Des; 2022; 28(39):3194-3201. PubMed ID: 34895117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
    Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
    Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
    Vitiello A; Ferrara F
    Respir Med; 2021 Mar; 178():106322. PubMed ID: 33550151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
    Elshafei MN; El-Bardissy A; Khalil A; Danjuma M; Mubasher M; Abubeker IY; Mohamed MFH
    Eur J Clin Invest; 2021 Sep; 51(9):e13645. PubMed ID: 34185313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care-COLCHICOVID study.
    Estebanez EB; Alconero LL; Fernández BJ; Marguello MG; Caro JCL; Vallejo JD; Sampedro MF; Cacho PM; Espiga CR; Saiz MMG
    Trials; 2021 Sep; 22(1):590. PubMed ID: 34488841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 With Preexisting Hypercoagulability Digestive Disease.
    Jiang M; Mu J; Shen S; Zhang H
    Front Med (Lausanne); 2020; 7():587350. PubMed ID: 33521013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
    Haimei MA
    Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
    Elshafei MN; Khalil A; El-Bardissy A; Danjuma M; Ahmed MB; Mohamed MFH
    Medicine (Baltimore); 2020 Sep; 99(36):e21911. PubMed ID: 32899023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality.
    Sandor-Keri J; Benedek I; Polexa S; Benedek I
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.